Core Viewpoint - Progyny, Inc. is facing potential claims from investors following the announcement of a significant client terminating its services agreement, which has led to a downgrade in the company's stock rating and a sharp decline in stock price [2]. Group 1: Company Developments - On September 18, 2024, Progyny disclosed that a significant client has elected to exercise a 90-day option to terminate its services agreement, effective January 1, 2025 [2]. - Following this announcement, JMP Securities downgraded Progyny from Outperform to Market Perform, citing concerns over potential lower retention rates due to the loss of its largest client [2]. - The stock price of Progyny fell sharply during intraday trading on September 19, 2024, in response to the news [2]. Group 2: Investigation and Legal Actions - Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Progyny securities and encourages investors to assist in the investigation [1][3]. - The firm represents investors in class actions on a contingency fee basis, meaning they will only seek reimbursement for expenses and attorneys' fees if successful [4]. - Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that has recovered hundreds of millions of dollars for investors in securities fraud class actions [5].
PGNY INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Progyny, Inc. and Encourages Investors to Contact the Firm!